Skip to main content
. 2008 Oct;15(7):370–374. doi: 10.1155/2008/946735

Figure 1).

Figure 1)

The costs of the different health resources in the two treatment strategies in the management of moderate to severe asthma. *P<0.05. ICS Inhaled corticosteroid; LABA Long-acting beta-agonist; Pred Prednisone; SABA Short-acting beta-agonist